Delivery Order SPE2DR25D1205-SPE2DR26F1BE3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,946.68 to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of February 19, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a subsidiary of Cencora, Inc., a major...
- The Defense Logistics Agency awarded a $6,973.34 delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 23, 2026, for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion deadline of February 13, 2026. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under the...
- The Defense Logistics Agency awarded a $27,893.36 delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of February 2, 2026. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $3,486.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on January 14, 2026, with completion scheduled for February 5, 2026. The order will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement requirements through open...
- The Defense Logistics Agency awarded a $6,973.34 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 29, 2026, for the supply of Benlysta 200 mg/ml auto-injector, with performance completion scheduled for February 20, 2026. This non-competitive delivery order was issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor as a child entity under its parent company, Cencora, Inc. (formerly Amerisourcebergen). The delivery will be performed at the contractor's...
- The Defense Logistics Agency awarded a $3,486.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp on February 2, 2026, for the supply of Benlysta 200 mg/ml auto-injector medication, with completion expected by February 24, 2026. This is a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a subsidiary of parent company Cencora, Inc. (which does business as...
- The Defense Logistics Agency awarded a $13,946.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical product. The contract was competitively awarded without set-aside designation and is scheduled for completion by February 13, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $6,973.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 27, 2026, for the supply of Benlysta 200 mg/ml auto-injectors. The order, which is a child contract with an ultimate completion date of February 18, 2026, carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,973.34 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of January 28, 2026. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and was executed on January 6, 2026. The awardee will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora,...
- The Defense Logistics Agency awarded a $10,460.01 delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Benlysta 200 mg/ml auto-injector medication, with performance completion targeted for January 27, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1BE3Delivery Order
The Defense Logistics Agency awarded a $13,946.68 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on February 4, 2026, for Benlysta 200 mg/mL auto-injector pharmaceutical supply. This is a firm fixed-price delivery order with no set-aside designation, utilizing a competitive procurement process. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of February 26, 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement and operates as a subsidiary of Cencora, Inc., a major healthcare solutions provider in the federal supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The contract supports critical federal healthcare systems including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen's established capability to fulfill specialized pharmaceutical requirements for military treatment facilities and other government healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 2/3/26 |